RPM International Inc (RPM) · Peers
RPM International against the 612 other companies here in its SEC industry, SIC 28xx (the wider group: its own four-digit code has fewer than five). Each figure is the one on the company's own page; the median is the peers', and the rank is among all 613, highest first.
Measure by measure
| Measure | RPM | Peer median | Rank |
|---|---|---|---|
| Market value | $12.74B | median $255.06M | 55 of 603 |
| P/E | 19.3× | median 20.7× | 84 of 151 |
| Forward P/E | 16.9× | median 16.9× | 86 of 170 |
| EV/EBITDA | 13.8× | median 14.2× | 89 of 176 |
| P/S | 1.6× | median 4.5× | 399 of 546 |
| FCF yield | 5.3% | median -9.0% | 94 of 588 |
| Dividend yield | 2.1% | median 2.4% | 53 of 94 |
| Gross margin | 41.4% | median 55.2% | 219 of 363 |
| Operating margin | 11.0% | median -19.0% | 106 of 453 |
| Net margin | 8.4% | median -16.3% | 102 of 438 |
| ROIC | 12.4% | median -11.6% | 78 of 361 |
| ROE | 20.0% | median -28.1% | 60 of 488 |
| Revenue growth (4y, yearly) | 4.1% | median 2.3% | 208 of 465 |
| EPS growth (yearly) | 8.1% | median -0.8% | 29 of 84 |
| Net debt / EBITDA | 2.0× | median 2.3× | 63 of 109 |
| Current ratio | 1.7× | median 3.2× | 414 of 595 |
| Stock pay / revenue | 0.4% | median 7.2% | 449 of 529 |
| Share count change | -0.5% | median 6.5% | 494 of 566 |
Green where RPM International is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| RPMRPM International Inc | $12.74B | P/E 19.3× | 12.4% | 5.0 |
| LLYELI LILLY & Co | $1.18T | P/E 44.3× | 41.2% | 6.1 |
| JNJJohnson & Johnson | $615.87B | P/E 29.3× | 18.2% | 5.6 |
| ABBVAbbVie Inc. | $504.37B | P/E 79.9× | 25.6% | 4.9 |
| PGPROCTER & GAMBLE Co | $370.40B | P/E 23.1× | 21.2% | 5.5 |
| MRKMerck & Co., Inc. | $360.08B | P/E 113.5× | 6.2% | 4.5 |
| NVSNovartis AG ADR | $287.41B | P/E 20.6× | 21.2% | 6.2 |
| AZNAstraZeneca PLC | $256.54B | P/E 25.1× | 14.6% | 5.9 |
| AMGNAmgen Inc | $233.82B | P/E 26.7× | 14.9% | 5.2 |
| LINLinde plc Ordinary Shares | $229.77B | P/E 31.7× | 11.9% | 5.1 |
| GSKGSK plc | $213.73B | P/E 25.8× | 20.1% | 5.9 |
| GILDGilead Sciences Inc | $193.67B | P/E – | -5.3% | 4.5 |
| ABTAbbott Laboratories | $182.70B | P/E 29.1× | 9.8% | 5.3 |
| NVONovo Nordisk A/S | $172.65B | P/E 11.3× | 31.6% | 6.5 |
| PFEPfizer Inc | $168.60B | P/E 21.7× | – | 5.0 |
| ULUnilever PLC ADR | $144.33B | P/E 13.0× | 18.9% | 5.2 |
| VRTXVertex Pharmaceuticals Inc | $126.66B | P/E 28.8× | 30.2% | 6.2 |
| BMYBristol-Myers Squibb Company | $122.05B | P/E 13.1× | 17.1% | 6.4 |
| HLNHaleon plc | $90.72B | P/E 41.0× | 8.0% | 5.2 |
| MRNAModerna, Inc. | $87.04B | P/E – | -116.5% | 2.8 |
| REGNRegeneron Pharmaceuticals Inc | $83.82B | P/E 19.4× | 11.5% | 5.7 |
| ECLEcolab Inc | $80.98B | P/E 38.3× | 12.5% | 4.8 |
| CLColgate-Palmolive Company | $75.02B | P/E 36.8× | 32.1% | 5.3 |
| APDAir Products & Chemicals, Inc. | $66.71B | P/E – | -3.6% | 3.9 |
| ARGXargenx NV ADR | $50.69B | P/E 39.2× | 21.5% | 6.0 |
| SNYSanofi | $49.53B | P/E 5.7× | 6.0% | 6.0 |
| TEVATeva Pharma Industries Ltd ADR | $48.36B | P/E 68.5× | 14.8% | 5.3 |
| BNTXBioNTech SE | $44.22B | P/E – | -24.2% | 4.1 |
| IDXXIDEXX Laboratories Inc | $44.15B | P/E 38.7× | 57.2% | 6.0 |
| ONCBeOne Medicines Ltd. | $38.72B | P/E 59.1× | 69.3% | 6.4 |
| RVMDRevolution Medicines, Inc. | $38.14B | P/E – | – | 2.9 |
| ELEstee Lauder Companies Inc | $38.14B | P/E 209.5× | 8.7% | 4.2 |
| KVUEKenvue Inc. | $36.32B | P/E 21.9× | 11.6% | 5.2 |
| BIIBBiogen Inc | $34.35B | P/E 25.0× | 6.2% | 5.3 |
| RPRXRoyalty Pharma plc | $33.95B | P/E 41.7× | 6.5% | 6.1 |
| NTRNutrien Ltd. | $33.20B | P/E 14.5× | 8.1% | 5.2 |
| ZTSZoetis Inc. | $32.80B | P/E 12.5× | 27.8% | 6.3 |
| ALNYAlnylam Pharmaceuticals Inc | $31.02B | P/E 42.3× | – | 5.6 |
| CHDChurch & Dwight Company Inc | $24.79B | P/E 33.3× | 13.7% | 5.5 |
| PPGPPG Industries Inc | $23.94B | P/E 15.1× | 15.2% | 5.4 |
| IFFInternational Flavors & Fragrances Inc | $23.14B | P/E 82.6× | 3.3% | 4.6 |
And 572 smaller ones.
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.